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and pulse were, respectively, 109/60 mmHg  and 110 beats/min
while supine. Breath sounds were diminished on the rightackground
uberculosis (TB) remains a major global health problem,
esponsible for the ill health of millions of people each year,
nd ranks as the second leading cause of death from an
nfectious disease worldwide.1 A variety of clinical manifes-
ations are associated directly or indirectly with TB. Among
hem, hematological abnormalities can be found in both
he pulmonary and extrapulmonary forms of the disease,
nd though a myriad of hematological disorders have been
escribed, anemia, leukocytosis, and pancytopenia are the
ost frequently cited.2 Thrombocytopenia is usually associ-
ted with disseminated or miliary TB and when it occurs, it
oes so most commonly via non-immunologic means, typi-
ally manifesting in the context of pancytopenia that develops
econdary to granulomatous inﬁltration of the bone marrow.3 causal association between TB and immune thrombocy-
openia (ITP) is extraordinarily rare and, to our knowledge,
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eserved.this is the ﬁrst documented case of pleural and pericardial TB
and ITP.
Case  report
60-year-old, previously healthy, Caucasian, male with a his-
tory of well-controlled hypertension was admitted to the
Emergency Room with new-onset hematuria and generalized
purpuric lesions. He also described a two-week history of
fever, dry cough, shortness of breath and pleuritic chest pain.
The patient was well nourished, with generalized nontender,
nonpalpable purpuric lesions, most evident in the extremi-
ties and trunk. He had an auricular temperature of 37.8 ◦C
and a respiratory rate of 22 breaths/min. His blood pressurea, Praceta Prof. Mota Pinto, 3000-075 Coimbra, Portugal.
side and the remainder of the physical examination was
normal.
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The initial complete blood count revealed a white blood
cell (WBC) count of 9.8 × 109/L with 75.4% granulocytes, 13.1%
lymphocytes, 11.1% monocytes, 0.3% eosinophils, and 0.1%
basophils, hemoglobin of 10.8 g/dL with a mean corpuscular
volume (MCV) of 85.6 ﬂ and a mean corpuscular hemoglobin
(MCH) of 30.0 pg, and platelet count of 2.0 × 109/L. A periph-
eral smear was remarkable for a paucity of platelets. The
ﬁndings of blood chemistries were normal and the follow-
ing laboratory studies were normal or negative: prothrombin
time/partial thromboplastin time, ﬁbrinogen, ﬁbrin degrada-
tion products (FDP), antinuclear antibodies (ANA), rheumatoid
factor, hepatitis C (HCV) and human immunodeﬁciency virus
(HIV). Anti-platelet antibodies were not tested. A chest X-ray
demonstrated bilateral pleural effusions, more  pronounced
on the right, a large heart shadow and clear lung ﬁelds.
Computed tomography of the chest revealed massive right
pleural effusion and a large pericardial effusion. M-mode
and 2D transthoracic echocardiogram revealed an organized
moderate-level anterior and posterior pericardial effusion,
without right ventricular collapse.
The patient was admitted to the Hematology Clinic where
he started a 5-day course of intravenous immunoglobulin
(IVIg), followed by oral corticosteroid therapy with pred-
nisone (1 mg/kg/day orally). The platelet count increased to
243 × 109/L and platelet transfusions were not required.
He was then transferred to our department to evaluate
the pleural and pericardial effusions. A laboratory evalua-
tion revealed a normal WBC  count, normocytic normochromic
anemia and normal platelet count. The erythrocyte sedi-
mentation rate (ESR) was elevated at 88 mm/h. The result
of tuberculin skin test was positive (22 mm).  A thoracentesis
was then performed, and the pleural ﬂuid revealed glu-
cose 37 mg/dL, protein 4.4 g/dL, lactate dehydrogenase (LDH)
890 U/L, adenosine deaminase (ADA) 90.1 U/L, with a WBC
count of 8.0 × 109/L including 66% of lymphocytes and no
malignant cells. Pleural ﬂuid acid-fast bacilli (AFB) smears
were negative but real-time polymerase chain reaction (PCR)
for the detection of Mycobacterium tuberculosis complex was
positive, posteriorly conﬁrmed by cultures of pleural ﬂuid
with the identiﬁcation of M. tuberculosis. Isoniazid, rifampin,
pyrazinamide, and ethambutol were started immediately and
the patient was discharged three weeks after admission.
Prednisone was tapered over eight weeks and stopped. Four
months after discharge, the patient, who  was in stable health
and with a platelet count of 253 × 109/L, was found to have
abnormal liver enzymes with a cholestatic pattern, thought
to be secondary to anti-tuberculous therapy (ATT). Doppler
ultrasonography of the liver showed hepatomegaly (176 mm),
dilated inferior vena cava and hepatic veins, with turbulent
ﬂow evidenced by color Doppler and a pulsatile waveform on
pulsed Doppler, suggesting right-sided heart failure. A liver
biopsy was performed which revealed sinusoidal dilatation
and congestion, with no granulomas and no evidence of AFB
or malignant cells. Cultures of the liver specimen were not per-
formed. For further clariﬁcation, cardiac magnetic resonance
imaging was then carried out which revealed thickening of
the pericardium (6 mm)  with signs of constriction, but without
evidence of pericardial effusion, and the patient underwent
pericardiectomy. Thrombocytopenia did not recur during the
follow-up.
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Discussion
ITP is an autoimmune disorder characterized by immunologic
destruction of otherwise normal platelets most commonly
occurring in response to an unknown stimulus. Classically
it occurs as one of two  forms: a childhood variety that is
acute, without gender predilection, post-viral and self-limited,
and the adult form that tends to be chronic. It may occur
in isolation (primary) or in association with other disorders
(secondary), including autoimmune diseases (particularly
antiphospholipid antibody syndrome), viral infections (includ-
ing HCV and HIV), and certain drugs. The diagnosis of ITP is
made by exclusion of secondary causes of thrombocytopenia
as there are no diagnostic tests to conﬁrm ITP, and in general,
bone marrow examination or assay of anti-platelet antibodies
are not needed for diagnosis if typical features are present. In
fact, anti-platelet antibodies were labeled as an ‘unnecessary’
test for the routine evaluation of patients presenting with ITP
according to the 2011 guidelines of the American Society for
Hematology, and the initial history and physical examination
should aim at identifying evidence of bleeding and exclud-
ing other causes of thrombocytopenia including secondary
ITP.4 The association between TB and ITP is exceedingly rare,
with few cases reported in the world literature.3 An immune
basis for TB-induced ITP was supported by the presence of
either platelet antigen speciﬁc antibodies or platelet surface
membrane IgG in three reports and by a salutary response to
immunomodulating treatments, as observed in our patient.
However, some cases failed to achieve a complete response to
immunomodulating therapies alone, which was only obtained
after ATT was started, supporting the etiologic role of TB
in producing ITP. Most authors used anti-tuberculosis drugs
combined with steroids and/or IVIg. Although rifampicin
has been implicated in causing thrombocytopenia, four drug
ATT regimens included rifampicin in all the cases with-
out worsening the condition. The exact duration of the
immunosuppressive therapy is not standardized and must be
individualized according to the hematological response. How-
ever, in most of the reported cases steroids were withdrawn
in 1–2 months.
In summary, TB-related ITP is a rare hematological man-
ifestation of a common disease. The actual pathophysiology,
clinical signiﬁcance and optimal treatment is not fully known,
but it should be recognized, especially in areas of high
endemicity, that TB-related ITP is treatable.
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